FIELD: medicine.
SUBSTANCE: rehabilitation of children with chronic microbial-inflammatory urinary diseases with the low immune status is ensured by the staged rehabilitation treatment of patients in the stage of complete and partial clinical and laboratory remission. The first stage involves a complex whereat the patient is exposed to ultraviolet short-wave beams according to the standard technique including tonsils, and endonasally according to the standard technique every second day within the 16-21-day therapeutic course. That is followed by a helper stimulation of a chest by means of Helper apparatus with using 19, 20 and 21 sternal point for 3-5 minutes for each within the 7-10-day daily therapeutic course. Therapeutic exercises and phytotherapy are prescribed next with using essences, namely sage, or mint, or aniseed, or eucalypt essences, every second day within the 7-10-day therapeutic course. Thereafter, 3-4 months later at the second stage of rehabilitation, inhalations with immunopotentiating agents, namely 0.5% lysozyme, or sodium nucleinate, or aralia infusion, or ginseng infusion, or eleuterococcus infusion, or aloe extract are prescribed in the form of 10-15 minute daily procedures. The adrenal glands are stimulated with a low-frequency alternating magnetic field generated by Polus-1 stimulator, daily for 10-20 minutes within the therapeutic course of 10-20 procedures. That is followed by the helper stimulation of a thymus by means of Helper apparatus with using 19, 20 and 21 sternal point for 3-5 minutes for each within the 7-10-day therapeutic course. The patient does therapeutic exercises. At the 3rd stage 3-4 months later, the patient is subject to an extremely high frequency electromagnetic exposure covering the middle one-third of the sternum for 5-25 minutes within the therapeutic course of 8-10 procedures, daily or every second day; or the thymus helper stimulation is applied; or a splenin or interferon phonophoresis on the submandibular lymph nodes is alternated with a complex immune preparation on wings of nose with the length of exposure 2-3 minutes within the therapeutic course of 8-10 procedures daily or every second day. The complex certainly includes a halotherapy consisting in 12-25 daily session of the length of 30 minutes, a chest massage and therapeutic exercises. The final 4th stage involves cold water treatment as provided by standard techniques, helper stimulation of the sternum and feet, therapeutic massage, therapeutic exercises, swimming, pine baths or contrast shower. The length and therapeutic course are selected individually for each child.
EFFECT: higher effectiveness of the rehabilitation treatment, namely the recovery of the main disease, reduced intercurrent infections, normalised immunogram ensured by the staged rehabilitation program aiming at the non-invasive targeted effect on the immune system.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT OF PATIENTS WHO HAVE HAD NEW CORONAVIRUS INFECTION WITH LUNG DAMAGE IN THE EARLY RECOVERY PERIOD | 2022 |
|
RU2801234C1 |
METHOD OF REHABILITATING SICKLY CHILDREN | 2010 |
|
RU2462220C2 |
METHOD FOR SANATORIUM-RESORT REHABILITATION OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2021 |
|
RU2765742C1 |
METHOD OF CHILDREN REHABILITATION SUFFERING FROM SUPERIOR DIGESTIVE DISORDERS ASSOCIATED WITH HELICOBACTER PYLORI | 2006 |
|
RU2328264C2 |
METHOD OF AFTERTREATMENT OF CHILDREN AND TEENAGERS WITH AUTOIMMUNE THYROIDITIS IN COMBINATION WITH CHRONIC PHARYNGOTONSILLITIS | 2006 |
|
RU2332978C2 |
METHOD FOR HALOTHERAPY IN OBSTRUCTIVE PULMONARY DISEASES | 2001 |
|
RU2211015C2 |
METHOD FOR COMPREHENSIVE REHABILITATION OF PATIENTS AFTER COVID-19 CORONAVIRUS INFECTION | 2021 |
|
RU2778774C1 |
METHOD OF PATIENT REHABILITATION FROM CHRONIC BRONCHOPULMONARY DISEASES | 2008 |
|
RU2370287C1 |
METHOD OF REHABILITATING TREATMENT OF PATIENTS WITH BRONCHIAL ASTHMA AND/OR CHRONIC OBSTRUCTIVE LUNG DISEASE | 2010 |
|
RU2428158C1 |
METHOD FOR TREATING CHRONIC BRONCHOPULMONARY PROCESS AT INBORN DEFECTS OF PULMONARY DEVELOPMENT IN CHILDREN | 2003 |
|
RU2253484C1 |
Authors
Dates
2014-06-20—Published
2013-04-17—Filed